Model‐Based Network Meta‐Analysis: A Framework for Evidence Synthesis of Clinical Trial Data

Model‐based meta‐analysis (MBMA) is increasingly used in drug development to inform decision‐making and future trial designs, through the use of complex dose and/or time course models. Network meta‐analysis (NMA) is increasingly being used by reimbursement agencies to estimate a set of coherent rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Mawdsley, D, Bennetts, M, Dias, S, Boucher, M, Welton, NJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999602/
https://www.ncbi.nlm.nih.gov/pubmed/27479782
http://dx.doi.org/10.1002/psp4.12091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999602/
https://www.ncbi.nlm.nih.gov/pubmed/27479782
http://dx.doi.org/10.1002/psp4.12091

Ejemplares similares